MOLECULAR MECHANISM OF ADIPOGENIC ACTIVATION OF THE ANGIOTENSINOGEN GENE

被引:27
|
作者
TAMURA, K
UMEMURA, S
IWAMOTO, T
YAMAGUCHI, S
KOBAYASHI, S
TAKEDA, K
TOKITA, Y
TAKAGI, N
MURAKAMI, K
FUKAMIZU, A
ISHII, M
机构
[1] YOKOHAMA CITY UNIV, SCH MED, DEPT INTERNAL MED 2, YOKOHAMA, KANAGAWA 236, JAPAN
[2] UNIV TSUKUBA, INST APPL BIOCHEM, IBARAKI, OSAKA, JAPAN
关键词
GENETICS; HYPERTENSION; OBESITY-INDUCED; ANGIOTENSINOGEN; ADIPOSE TISSUE;
D O I
10.1161/01.HYP.23.3.364
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensinogen gene expression is controlled in a tissue- and development-specific manner. Interestingly, the angiotensinogen gene is abundantly expressed in adipose tissues other than the liver, where it is mainly produced. We investigated the molecular mechanism of angiotensinogen gene expression in a 3T3-L1 preadipocyte-adipocyte system. Although angiotensinogen mRNA was barely detectable in preadipocytes, its levels increased significantly during differentiation. As a whole, the pattern of the change in transcriptional activity of the angiotensinogen promoter was similar to that of the angiotensinogen mRNA levels during adipogenic differentiation, indicating that the activation of the angiotensinogen promoter might be involved in the adipogenic differentiation-coupled gene expression. The proximal promoter region, from -96 to +22 of the transcriptional start site, was sufficient to confer adipogenic activation, and the proximal element from -96 to -52 of the transcriptional start site was necessary for this promoter stimulation. DNA-protein binding experiments showed that this proximal element specifically bound to a nuclear factor induced by adipogenic differentiation. These results suggest that the proximal promoter element from -96 to -52 plays a role in adipogenic activation of the angiotensinogen promoter.
引用
收藏
页码:364 / 368
页数:5
相关论文
共 50 条
  • [31] STRUCTURE AND REGULATION OF THE ANGIOTENSINOGEN GENE
    IBARRARUBIO, ME
    PEDRAZACHAVERRI, J
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1993, 45 (04): : 387 - 398
  • [32] Angiotensinogen gene and hypertension in Chinese
    Niu, TH
    Xu, XP
    Rogus, J
    Zhou, YS
    Chen, CZ
    Yang, JH
    Fang, Z
    Schmitz, C
    Zhao, JH
    Rao, VS
    Lindpaintner, K
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01): : 188 - 194
  • [33] MOLECULAR-BIOLOGY OF ANGIOTENSINOGEN
    LYNCH, KR
    PEACH, MJ
    HYPERTENSION, 1991, 17 (03) : 263 - 269
  • [34] Malignant hypertension and the angiotensinogen gene
    Handtrack, Claudia
    Hilgers, Karl F.
    JOURNAL OF HYPERTENSION, 2007, 25 (11) : 2199 - 2201
  • [35] FETAL EXPRESSION OF THE ANGIOTENSINOGEN GENE
    GOMEZ, RA
    CASSIS, L
    LYNCH, KR
    CHEVALIER, RL
    WILFONG, N
    CAREY, RM
    PEACH, MJ
    ENDOCRINOLOGY, 1988, 123 (05) : 2298 - 2302
  • [36] Angiotensinogen gene polymorphism and hypertension
    Kumar, A
    Jain, S
    Li, YN
    Patil, S
    HYPERTENSION, 2004, 44 (04) : 560 - 561
  • [37] Angiotensinogen gene haplotypes in hypertension
    Brugts, Jasper J.
    de Maat, Moniek P. M.
    den Uil, Corstiaan A.
    Danser, Jan A. H.
    JOURNAL OF HYPERTENSION, 2008, 26 (12) : 2451 - 2452
  • [38] DNA BENDING AND THE MECHANISM OF GENE ACTIVATION
    CROTHERS, DM
    BERMAN, S
    STRANEY, D
    WU, HM
    FEDERATION PROCEEDINGS, 1985, 44 (03) : R8 - R8
  • [39] Molecular mechanism of polyhomeotic activation by Engrailed
    Serrano, N
    Maschat, F
    EMBO JOURNAL, 1998, 17 (13): : 3704 - 3713
  • [40] MOLECULAR MECHANISM OF PPARγ ACTIVATION BY RESVERATROL
    Takizawa, Y.
    Nakata, R.
    Matsushita, K.
    Hongo, S.
    Matsumoto, A.
    Takai, A.
    Inoue, H.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1629 - 1630